Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND) (STAND)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02179333 |
Recruitment Status :
Completed
First Posted : July 1, 2014
Last Update Posted : November 16, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The objectives of this study are:
- To validate the inter-rater and intra-rater reliability of a new scale for the assessment of ataxia and neurologic dysfunction (STAND)
- To assess common constructs and correlation between STAND subscale items.
Condition or disease | Intervention/treatment |
---|---|
Spinocerebellar Ataxia - All Sub-types Friedreich's Ataxia | Other: Ataxia rating scale |
Study Type : | Observational |
Actual Enrollment : | 30 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND) |
Study Start Date : | October 2012 |
Actual Primary Completion Date : | June 2016 |
Actual Study Completion Date : | June 2016 |

Group/Cohort | Intervention/treatment |
---|---|
Subjects with Ataxia
Patients with a diagnosis of ataxia (Friedreich's ataxia or Spinocerebellar ataxia type 1-30) aged 18-80 years old will be recruited for the study.
|
Other: Ataxia rating scale
Administer new rating scale for ataxia. This will be administered by two different raters on two separate occassions, 4 to 6 weeks apart. |
- Inter- and intra-rater agreement [ Time Frame: 4 to 6 weeks ]Assess agreement between raters (inter-rater agreement) and within raters (intra-rater agreement) through the evaluation of STAND total score, subtotals and individual variables using intraclass correlation coefficients (ICCs).

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Diagnosis of ataxia.
- Male or female between 18 and 80 years of age.
- Subject has voluntarily signed an IRB approved informed consent form to participate in the study after all relevant aspects of the study have been explained and discussed with the subject.
Exclusion Criteria:
- Any illness that in the investigator's opinion preclude participation in this study.
- Subjects with a cardiac pacemaker
- Legal incapacity or limited legal capacity.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02179333
United States, Florida | |
University of South Florida | |
Tampa, Florida, United States, 33612 |
Responsible Party: | Theresa Zesiewicz, MD, Professor of Neurology, University of South Florida |
ClinicalTrials.gov Identifier: | NCT02179333 |
Other Study ID Numbers: |
STAND2012 |
First Posted: | July 1, 2014 Key Record Dates |
Last Update Posted: | November 16, 2021 |
Last Verified: | November 2021 |
Ataxia Cerebellar Ataxia Spinocerebellar Ataxias Spinocerebellar Degenerations Friedreich Ataxia Neurologic Manifestations Dyskinesias Nervous System Diseases Cerebellar Diseases |
Brain Diseases Central Nervous System Diseases Spinal Cord Diseases Heredodegenerative Disorders, Nervous System Neurodegenerative Diseases Genetic Diseases, Inborn Mitochondrial Diseases Metabolic Diseases |